CABA Valuation

Cabaletta Bio Inc

Add to Watchlist

Advanced Chart

1.645

-0.015(-0.904%)1D

Overview
Forecast
Valuation
Earnings

CABA Relative Valuation

CABA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CABA is overvalued; if below, it's undervalued.

Historical Valuation

Cabaletta Bio Inc (CABA) is now in the Fair zone, suggesting that its current forward PS ratio of 18.95 is considered Fairly compared with the five-year average of -4.40. The fair price of Cabaletta Bio Inc (CABA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.66

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.67

P/B

Median3y

2.18

Median5y

2.07

-68.41

FCF Yield

Median3y

-46.39

Median5y

-39.95

Competitors Valuation Multiple

The average P/S ratio for CABA's competitors is 8.48, providing a benchmark for relative valuation. Cabaletta Bio Inc Corp (CABA) exhibits a P/S ratio of 18.95, which is 123.44% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap